Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Hepcidin-guided screen-and-treat interventions against iron-deficiency anaemia in pregnancy: a randomised controlled trial in The Gambia.

Bah A, Muhammad AK, Wegmuller R, Verhoef H, Goheen MM, Sanyang S, Danso E, Sise EA, Pasricha SR, Armitage AE, Drakesmith H, Cross JH, Moore SE, Cerami C, Prentice AM.

Lancet Glob Health. 2019 Nov;7(11):e1564-e1574. doi: 10.1016/S2214-109X(19)30393-6.

2.

The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia.

Muriuki JM, Mentzer AJ, Band G, Gilchrist JJ, Carstensen T, Lule SA, Goheen MM, Joof F, Kimita W, Mogire R, Cutland CL, Diarra A, Rautanen A, Pomilla C, Gurdasani D, Rockett K, Mturi N, Ndungu FM, Scott JAG, Sirima SB, Morovat A, Prentice AM, Madhi SA, Webb EL, Elliott AM, Bejon P, Sandhu MS, Hill AVS, Kwiatkowski DP, Williams TN, Cerami C, Atkinson SH.

Sci Adv. 2019 Sep 4;5(9):eaaw0109. doi: 10.1126/sciadv.aaw0109. eCollection 2019 Sep.

3.

Host iron status and erythropoietic response to iron supplementation determines susceptibility to the RBC stage of falciparum malaria during pregnancy.

Goheen MM, Bah A, Wegmüller R, Verhoef H, Darboe B, Danso E, Prentice AM, Cerami C.

Sci Rep. 2017 Dec 15;7(1):17674. doi: 10.1038/s41598-017-16896-z.

4.

The role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations.

Goheen MM, Campino S, Cerami C.

Br J Haematol. 2017 Nov;179(4):543-556. doi: 10.1111/bjh.14886. Epub 2017 Aug 23. Review.

5.

Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron Supplementation.

Goheen MM, Wegmüller R, Bah A, Darboe B, Danso E, Affara M, Gardner D, Patel JC, Prentice AM, Cerami C.

EBioMedicine. 2016 Dec;14:123-130. doi: 10.1016/j.ebiom.2016.11.011. Epub 2016 Nov 9.

6.
7.

Biopreservation of RBCs for in vitro Plasmodium falciparum culture.

Goheen MM, Clark MA, Kasthuri RS, Cerami C.

Br J Haematol. 2016 Nov;175(4):741-744. doi: 10.1111/bjh.13882. Epub 2016 Jan 15. No abstract available.

8.

Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum.

Clark MA, Goheen MM, Fulford A, Prentice AM, Elnagheeb MA, Patel J, Fisher N, Taylor SM, Kasthuri RS, Cerami C.

Nat Commun. 2014 Jul 25;5:4446. doi: 10.1038/ncomms5446.

9.

RBC barcoding allows for the study of erythrocyte population dynamics and P. falciparum merozoite invasion.

Clark MA, Goheen MM, Spidale NA, Kasthuri RS, Fulford A, Cerami C.

PLoS One. 2014 Jul 1;9(7):e101041. doi: 10.1371/journal.pone.0101041. eCollection 2014.

10.

Independent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa.

Taylor SM, Antonia AL, Harrington WE, Goheen MM, Mwapasa V, Chaluluka E, Fried M, Kabyemela E, Madanitsa M, Khairallah C, Kalilani-Phiri L, Tshefu AK, Rogerson SJ, Ter Kuile FO, Duffy PE, Meshnick SR.

Emerg Infect Dis. 2014 Jul;20(7):1140-8. doi: 10.3201/eid2007.131720.

11.

Influence of host iron status on Plasmodium falciparum infection.

Clark MA, Goheen MM, Cerami C.

Front Pharmacol. 2014 May 6;5:84. doi: 10.3389/fphar.2014.00084. eCollection 2014. Review.

12.

Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model.

Kari L, Bakios LE, Goheen MM, Bess LN, Watkins HS, Southern TR, Song L, Whitmire WM, Olivares-Zavaleta N, Caldwell HD.

PLoS Negl Trop Dis. 2013 May 30;7(5):e2248. doi: 10.1371/journal.pntd.0002248. Print 2013.

13.

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.

Kari L, Whitmire WM, Olivares-Zavaleta N, Goheen MM, Taylor LD, Carlson JH, Sturdevant GL, Lu C, Bakios LE, Randall LB, Parnell MJ, Zhong G, Caldwell HD.

J Exp Med. 2011 Oct 24;208(11):2217-23. doi: 10.1084/jem.20111266. Epub 2011 Oct 10.

14.

Generation of targeted Chlamydia trachomatis null mutants.

Kari L, Goheen MM, Randall LB, Taylor LD, Carlson JH, Whitmire WM, Virok D, Rajaram K, Endresz V, McClarty G, Nelson DE, Caldwell HD.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7189-93. doi: 10.1073/pnas.1102229108. Epub 2011 Apr 11.

15.

Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.

Sturdevant GL, Kari L, Gardner DJ, Olivares-Zavaleta N, Randall LB, Whitmire WM, Carlson JH, Goheen MM, Selleck EM, Martens C, Caldwell HD.

Infect Immun. 2010 Sep;78(9):3660-8. doi: 10.1128/IAI.00386-10. Epub 2010 Jun 14.

16.

Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, Goheen MM, Peterson EM, Pal S, de la Maza LM, Caldwell HD.

J Immunol. 2009 Jun 15;182(12):8063-70. doi: 10.4049/jimmunol.0804375.

17.

Inhibition of chlamydiae by primary alcohols correlates with the strain-specific complement of plasticity zone phospholipase D genes.

Nelson DE, Crane DD, Taylor LD, Dorward DW, Goheen MM, Caldwell HD.

Infect Immun. 2006 Jan;74(1):73-80.

18.

Chlamydial infection induces pathobiotype-specific protein tyrosine phosphorylation in epithelial cells.

Virok DP, Nelson DE, Whitmire WM, Crane DD, Goheen MM, Caldwell HD.

Infect Immun. 2005 Apr;73(4):1939-46.

Supplemental Content

Loading ...
Support Center